BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4280885)

  • 21. In vitro effects of suramin on Trypanosoma cruzi.
    Bisaggio DF; Adade CM; Souto-Padrón T
    Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of trypanocidal drugs on terminal respiration of Crithidia fasciculata.
    Hill GC; Hutner SH
    Exp Parasitol; 1968 Apr; 22(2):207-12. PubMed ID: 4231492
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug effects on the fine structure of Trypanosoma rhodesiense: puromycin and its aminonucleoside, Cordycepin and Nucleocidin.
    Williamson J; Macadam RF
    Trans R Soc Trop Med Hyg; 1976; 70(2):130-7. PubMed ID: 1085509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Brazilian isolates of Trypanosoma evansi to suramin sodium: test in experimentally infected mice.
    Faccio L; Da Silva AS; Gressler LT; Tonin AA; Lazzarotto CR; Miletti LC; Monteiro SG
    Exp Parasitol; 2013 Jul; 134(3):309-12. PubMed ID: 23562880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of suramin and sodium salicylate on the morphological variation and virulence of two strains of Trypanosoma rhodesiense in mice.
    Vaughan JP
    Ann Trop Med Parasitol; 1969 Sep; 63(3):301-7. PubMed ID: 5373664
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of suramin on blood and tissue forms of Trypanosoma brucei and Trypanosoma rhodesiense.
    Woo P; Soltys MA
    Ann Trop Med Parasitol; 1971 Dec; 65(4):465-9. PubMed ID: 5145111
    [No Abstract]   [Full Text] [Related]  

  • 30. New Trypanosoma evansi Type B Isolates from Ethiopian Dromedary Camels.
    Birhanu H; Gebrehiwot T; Goddeeris BM; Büscher P; Van Reet N
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004556. PubMed ID: 27035661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The trypanocidal activity of some pyrimidylaminophenylarsonic compounds.
    AINLEY AD; DAVEY DG
    Br J Pharmacol Chemother; 1958 Sep; 13(3):244-9. PubMed ID: 13584724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma brucei: suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase.
    Fairlamb AH; Bowman IB
    Exp Parasitol; 1977 Dec; 43(2):353-61. PubMed ID: 598447
    [No Abstract]   [Full Text] [Related]  

  • 35. [Light- and electronmicroscopic studies on mastigote and amastigote stages of Trypanosoma cruzi under the influence of Lampit (author's transl)].
    Voigt WH; Haberkorn A; Gönnert R
    Z Parasitenkd; 1973 Jul; 41(4):255-67. PubMed ID: 4355120
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug sensitivity of pleomorphic Trypanosoma rhodesiense.
    Williamson J
    Trans R Soc Trop Med Hyg; 1983; 77(2):192-3. PubMed ID: 6223414
    [No Abstract]   [Full Text] [Related]  

  • 37. Trypanosoma evansi: measurement of pyruvate production as an indicator of the drug sensitivity of isolates in vitro.
    Sutherland DV; Barns AM; Ross CA
    Trop Med Parasitol; 1995 Jun; 46(2):93-8. PubMed ID: 8525292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanocidal and antitumour activity of platinum-metal and platinum-metal-drug dual-function complexes.
    Farrell NP; Williamson J; McLaren DJ
    Biochem Pharmacol; 1984 Apr; 33(7):961-71. PubMed ID: 6538791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi.
    Gillingwater K; Kumar A; Ismail MA; Arafa RK; Stephens CE; Boykin DW; Tidwell RR; Brun R
    Vet Parasitol; 2010 May; 169(3-4):264-72. PubMed ID: 20149544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.